NeurologyLive® Staff

Articles by NeurologyLive® Staff

Dravet Syndrome Foundation Hosts Research Roundtable at AES 2019

ByNeurologyLive® Staff

December 4th 2019

The 10th annual DSF Research Roundtable will take place on Thursday, December 5, in Baltimore, Maryland.

FDA Granted Approval to Cenobamate, Risdiplam is Granted Priority Review Designation, Riluzole Oral Film FDA Approved for Treatment of ALS

ByNeurologyLive® Staff

November 30th 2019

Neurology News Network for the week ending November 30, 2019.

Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia

ByNeurologyLive® Staff

November 23rd 2019

Neurology News Network for the week ending November 23, 2019.

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

ByNeurologyLive® Staff

November 16th 2019

Neurology News Network for the week ending November 16, 2019.

Acute Ischemic Stroke Guidelines Updated, Stephen Hahn Nominated for FDA, Satralizumab Reduces Risk of Relapse in NMOSD

ByNeurologyLive® Staff

November 9th 2019

Neurology News Network for the week ending November 9, 2019.

Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold

ByNeurologyLive® Staff

November 2nd 2019

Neurology News Network for the week ending October 28, 2019.

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

ByNeurologyLive® Staff

October 26th 2019

Neurology News Network for the week ending October 26, 2019.

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

ByNeurologyLive® Staff

October 19th 2019

Neurology News Network for the week ending October 19, 2019.

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

ByNeurologyLive® Staff

October 12th 2019

Neurology News Network for the week ending October 12, 2019.

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

ByNeurologyLive® Staff

October 5th 2019

Neurology News Network for the week ending October 5, 2019.

Are Multiple Sclerosis Treatment Prices Interfering With Patient Care?

ByNeurologyLive® Staff

October 4th 2019

Unsustainable costs pose challenges for patients and providers alike as the price of living with MS continues to rise.

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

ByNeurologyLive® Staff

September 28th 2019

Neurology News Network for the week ending September 28, 2019.

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

ByNeurologyLive® Staff

September 21st 2019

Neurology News Network for the week ending September 21, 2019.

NeurologyLive Adds Montefiore Health System to Its Strategic Alliance Partnership Program

ByNeurologyLive® Staff

September 16th 2019

Montefiore Health System will also be working with The American Journal for Managed Care.

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

ByNeurologyLive® Staff

September 14th 2019

Neurology News Network for the week ending September 14, 2019.

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

ByNeurologyLive® Staff

September 7th 2019

Neurology News Network for the week ending September 7, 2019.

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

ByNeurologyLive® Staff

August 31st 2019

Neurology News Network for the week ending August 31, 2019.

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

ByNeurologyLive® Staff

August 24th 2019

Neurology News Network for the week ending August 24, 2019.

Impact of Caregiver Depression on Patients With Dementia, CAG Repeat Length Predicts Huntington Disease Decline, Novel Oral CBD Formulation Effective in Epilepsy

ByNeurologyLive® Staff

August 17th 2019

Neurology News Network for the week ending August 17, 2019.

Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast

ByNeurologyLive® Staff

August 10th 2019

Neurology News Network for the week ending August 10, 2019.

Tic Suppression Ability Predicts Future Symptom Outcomes, Wearable-Detected Gait Changes Predict Parkinson Disease, Early MRI Scans Predict Relapse-Onset Multiple Sclerosis

ByNeurologyLive® Staff

August 3rd 2019

Neurology News Network for the week ending August 3, 2019.

Happy Anniversary, NeurologyLive!

ByNeurologyLive® Staff

August 1st 2019

On our anniversary, take a look back at some of our most popular articles and interviews across a range of neurology topics.

Highlights From the 2019 American Headache Society Annual Scientific Meeting

ByNeurologyLive® Staff

July 24th 2019

This week’s edition features highlights from NeurologyLive’s coverage of the American Headache Society’s annual scientific meeting.

Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy

ByNeurologyLive® Staff

July 13th 2019

Neurology News Network for the week ending July 13, 2019.

Nusinersen Shows Long-Term SMA Success, Positive Data for an Investigational DMD Therapy, Zogenix to Resubmit Fenfluramine NDA

ByNeurologyLive® Staff

July 6th 2019

Neurology News Network for the week ending July 6, 2019.

Perampanel Monotherapy Promotes Seizure Freedom, Intranasal Midazolam Rapidly Effective, Safe Alternative in Status Epilepticus, Sleep Disorders and Epilepsy

ByNeurologyLive® Staff

June 29th 2019

Neurology News Network for the week ending June 29, 2019.

Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness

ByNeurologyLive® Staff

June 22nd 2019

Neurology News Network for the week ending June 22, 2019.

ILAE MRI Recommendations, CPAP in OSA and MCI, Lemborexant Positive for Insomnia

ByNeurologyLive® Staff

June 15th 2019

Neurology News Network for the week ending June 15, 2019.

FDA Approves Galcanezumab for Episodic Cluster Headache, FDA Clears ReStore Exo-Suit for Stroke Rehabilitation, Alzheimer Disease May Be Influenced by LDL-C Levels

ByNeurologyLive® Staff

June 8th 2019

Neurology News Network for the week ending June 8, 2019.

FDA Approves Zolgensma for Spinal Muscular Atrophy, Nerivio Migra Device Granted De Novo Clearance for Migraine, Cladribine Reduces MRI Lesions Across Subgroups in ORACLE-MS Study

ByNeurologyLive® Staff

June 1st 2019

Neurology News Network for the week ending June 1, 2019.

NeurologyLive® Staff

Articles by NeurologyLive® Staff

Dravet Syndrome Foundation Hosts Research Roundtable at AES 2019

FDA Granted Approval to Cenobamate, Risdiplam is Granted Priority Review Designation, Riluzole Oral Film FDA Approved for Treatment of ALS

Ubrogepant Provides Pain Relief for Acute Migraine, Cenobamate Reduces Focal-onset Seizures, Valbenazine Decreases Involuntary Movements in Patients with Tardive Dyskinesia

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

Acute Ischemic Stroke Guidelines Updated, Stephen Hahn Nominated for FDA, Satralizumab Reduces Risk of Relapse in NMOSD

Diroximel Fumarate Approved for MS; Personalized Interventions Improve Cognition; Zolgensma Trial Placed on Partial Hold

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

Are Multiple Sclerosis Treatment Prices Interfering With Patient Care?

EMA Removes Pregnancy Contraindications From MS Drugs, Oral Tavapadon Effective in Early-Stage Parkinson Disease, Pimavanserin Reduces Depression in PD

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

NeurologyLive Adds Montefiore Health System to Its Strategic Alliance Partnership Program

Acadia Halts Phase 3 Pimavanserin Trial, Ofatumumab Superior In MS, Satralizumab Shines in NMOSD at ECTRIMS 2019

MS Immunization Guidelines, Prognostic Value of NfL in ALS, the Future of Focused Ultrasound

Istradefylline OK'd for Parkinson, RimabotulinumtoxinB Approved for Chronic Sialorrhea, Dementia in Chronic Truamatic Encephalopathy

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

Impact of Caregiver Depression on Patients With Dementia, CAG Repeat Length Predicts Huntington Disease Decline, Novel Oral CBD Formulation Effective in Epilepsy

Zolgensma Gene Therapy Data Manipulation, GRF6019 Phase 2 Results in Mild to Moderate Alzheimer, Mind Moments Podcast

Tic Suppression Ability Predicts Future Symptom Outcomes, Wearable-Detected Gait Changes Predict Parkinson Disease, Early MRI Scans Predict Relapse-Onset Multiple Sclerosis

Happy Anniversary, NeurologyLive!

Highlights From the 2019 American Headache Society Annual Scientific Meeting

Parkinson Disease Gene Therapy PR001 Granted Fast Track Designation, Telerehabilitation Similar to In-Clinic Rehab for Stroke, New Therapeutic Technologies In Epilepsy

Nusinersen Shows Long-Term SMA Success, Positive Data for an Investigational DMD Therapy, Zogenix to Resubmit Fenfluramine NDA

Perampanel Monotherapy Promotes Seizure Freedom, Intranasal Midazolam Rapidly Effective, Safe Alternative in Status Epilepticus, Sleep Disorders and Epilepsy

Solriamfetol Receives Schedule IV Designation for EDS in Narcolepsy, OSA, ABO-202 Gene Therapy Granted Fast Track Designation for Batten Disease, NfL Shows Multi-disease Usefulness

ILAE MRI Recommendations, CPAP in OSA and MCI, Lemborexant Positive for Insomnia

FDA Approves Galcanezumab for Episodic Cluster Headache, FDA Clears ReStore Exo-Suit for Stroke Rehabilitation, Alzheimer Disease May Be Influenced by LDL-C Levels

FDA Approves Zolgensma for Spinal Muscular Atrophy, Nerivio Migra Device Granted De Novo Clearance for Migraine, Cladribine Reduces MRI Lesions Across Subgroups in ORACLE-MS Study

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

How Multiple Sclerosis Affects Men

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds

Key Highlights from the 2025 American Neurological Association Annual Meeting

This Week on NeurologyLive® — October 13, 2025